Guangzhou Patronus Biotech Co., Ltd.

This study tests a new vaccine called LYB005 to protect older adults (60 years and older) from respiratory syncytial virus (RSV), a common virus that can cause serious lung infections in seniors. About 700 participants will receive either the vaccine or a placebo to check if the …

This study tests a new vaccine called LYB004 to see if it can safely protect adults aged 40 and older from shingles, a painful rash caused by the chickenpox virus. About 840 participants in China will receive the vaccine and be monitored for side effects and immune response. The …